Tiotropium Respimat® 2.5 mg Add-on to ICS or ICS plus controller medications Improves Lung Function in Adults and Adolescents With Mild, Moderate, or Severe Symptomatic Asthma

被引：0
|
作者：
Berger, William E. [1 ]
Meltzer, Eli O. [2 ]
Unseld, Anna [3 ]
Shaikh, Asif [4 ]
Engel, Michael [5 ]
机构：
[1] Southern Calif Res Ctr, Mission Viejo, CA USA
[2] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[3] Boehringer Ingelheim Pharma GmbH & Co KG, Global Biometr & Data Sci, Biberach, Germany
[4] Boehringer Ingelheim Pharmaceut Inc, Clin Dev & Data Sci, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[5] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.312
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
302
引用
收藏
页码：AB96 / AB96
页数：1
相关论文
共 50 条
  • [41] Tiotropium Respimat® Add-On Therapy Reduces Exacerbation Risk In Patients With Symptomatic Moderate To Severe Asthma, Independent Of T Helper 2 Status
    Casale, T. B.
    Dahl, R.
    Virchow, J. C.
    Engel, M.
    Moroni-Zentgraf, P.
    Luehmann, R.
    Kerstjens, H. A. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [42] TIOTROPIUM RESPIMAT® ADD-ON THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH SYMPTOMATIC MODERATE TO SEVERE ASTHMA, INDEPENDENT OF T HELPER 2 STATUS
    Philips, M.
    Casale, T.
    Dahl, R.
    Virchow, J.
    Engel, M.
    Moroni-Zentgraf, P.
    Luehmann, R.
    Kerstjens, H.
    RESPIROLOGY, 2016, 21 : 107 - 107
  • [43] Once-Daily Tiotropium Respimat Add-on to Inhaled Corticosteroids Over 1 Year Improves Lung Function in Adolescent Patients With Moderate Symptomatic Asthma, Independent of Patients Baseline Characteristics
    Vandewalker, Mark
    Harper, Thomas
    Moroni-Zentgraf, Petra
    Engel, Michael
    Luehmann, Reinhold
    Bernstein, Jonathan
    CHEST, 2015, 148 (04)
  • [44] TIOTROPIUM RESPIMAT (R) ADD-ON THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH MODERATE OR SEVERE SYMPTOMATIC ASTHMA, INDEPENDENT OF TH2 STATUS
    Casale, T.
    Dahl, R.
    Virchow, J. C.
    Engel, M.
    Moroni-Zentgraf, P.
    Luehmann, R.
    Kerstjens, H. A. M.
    THORAX, 2015, 70 : A152 - A153
  • [45] Once-Daily Tiotropium Respimat® Add-on to at Least Ics Maintenance Therapy in Patients with Symptomatic Asthma: Methodology of Modeling Analyses By Serum IgE and Blood Eosinophil Levels
    Schmidt, Hendrik
    Moroni-Zentgraf, Petra
    Engel, Michael
    Dahl, Ronald
    Kerstjens, Huib A. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB212 - AB212
  • [46] Once-Daily Tiotropium Respimat® Add-on to at Least Ics Maintenance Therapy Demonstrates Improved Asthma Control in Patients with Symptomatic Asthma, Independent of Serum IgE or Blood Eosinophil Levels
    Vandewalker, Mark L.
    Virchow, Johann Christian
    Casale, Thomas B.
    Engel, Michael
    Moroni-Zentgraf, Petra
    Luehmann, Reinhold
    Dahl, Ronald
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB210 - AB210
  • [47] Asthma Treatment With Add-On Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improved Lung Function and Asthma Control Compared With Placebo Plus High-Dose ICS
    Busse, William
    Castro, Mario
    Lugogo, Njira
    O'Byrne, Paul
    Bacharier, Leonard
    Xia, Changming
    Hardin, Megan
    Soliman, Mena
    Sacks, Harry
    Jacob-Nara, Juby
    Rowe, Paul
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB368 - AB368
  • [48] Safety and tolerability of once-daily tiotropium Respimat® add-on to at least inhaled corticosteroid maintenance therapy in adolescent patients with moderate or severe symptomatic asthma
    Dahl, R.
    Szefler, S. J.
    Bernstein, J.
    Vandewalker, M.
    Engel, M.
    Moroni-Zentgraf, P.
    Unseld, A.
    Hamelmann, E.
    ALLERGY, 2015, 70 : 34 - 35
  • [49] Once-Daily Tiotropium Respimat® Improves Lung Function In Patients With Severe Symptomatic Asthma Independent Of Leukotriene Modifier Use
    Dahl, Ronald
    Doherty, Dennis E.
    Corren, Jonathan
    Karpel, Jill
    Kerstjens, Huib A. M.
    Engel, Michael
    Moroni-Zentgraf, Petra
    Schmidt, Hendrik
    Hashimoto, Shu
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB5 - AB5
  • [50] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO INHALED CORTICOSTEROIDS ± LONG-ACTING β2-AGONISTS IMPROVES LUNG FUNCTION AND ASTHMA CONTROL AND REDUCES RISK OF ASTHMA WORSENING IN PATIENTS WITH MODERATE OR SEVERE ASTHMA.
    Murphy, K.
    Bensch, G.
    Berger, W. E.
    Engel, M.
    Schmidt, H.
    Moroni-Zentgraf, P.
    Kerstjens, H. A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A107 - A107
12345